Editorials Trials are best, ignore the rest: safety and efficacy of digoxin BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h4662 (Published 30 August 2015) Cite this as: BMJ 2015;351:h4662 Article Related content Metrics Responses Peer review Related articles Research Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data Published: 30 August 2015; BMJ 351 doi:10.1136/bmj.h4451 Analysis Perioperative β blockade: guidelines do not reflect the problems with the evidence from the DECREASE trials Published: 29 August 2014; BMJ 349 doi:10.1136/bmj.g5210 ResearchSafety and efficacy of digoxin See more Dengue: Argentinians turn to homemade repellent amid surge in cases BMJ April 17, 2024, 385 q885; DOI: https://doi.org/10.1136/bmj.q885 Devolved powers for Greater Manchester led to some health improvements, study shows BMJ March 28, 2024, 384 q767; DOI: https://doi.org/10.1136/bmj.q767 Long waits in child mental health are a “ticking time bomb” regulator warns BMJ March 22, 2024, 384 q724; DOI: https://doi.org/10.1136/bmj.q724 Doctors report big rise in patients with illness because of socioeconomic factors BMJ March 01, 2024, 384 q538; DOI: https://doi.org/10.1136/bmj.q538 Diphtheria: WHO publishes first ever guidance following outbreaks BMJ February 14, 2024, 384 q407; DOI: https://doi.org/10.1136/bmj.q407
